The Directory of Pharma Companies and News


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Category: Pharmaco
Category: Pharmaco
Keywords: oncology,

AstraZeneca News

2015-10-16AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination
2015-09-30New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis
2015-09-24AstraZeneca presents advances in oncology research at ECC 2015 with data on AZD9291, durvalumab and LYNPARZA™ (olaparib)
2015-09-22AstraZeneca to present data demonstrating diversity of its portfolio of innovative formulations and devices at the Europ...
2015-09-17AstraZeneca presents positive pooled analysis demonstrating the effect of dapagliflozin on albuminuria in hypertensive p...
2015-09-15AstraZeneca announces new tolerability, long-term efficacy and real-world adherence data for exenatide once weekly in pa...
2015-09-11AstraZeneca to present comprehensive data from its diabetes portfolio and pre-clinical research at EASD 2015
2015-09-11AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
2015-09-08AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manches...
2015-09-04AstraZeneca to update on leading lung cancer portfolio at WCLC 2015
2015-09-03US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
2015-09-02AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of FluMist in Japan
2015-09-02Positive Phase III results demonstrate efficacy of antibiotic medicine CAZ-AVI in complicated Urinary Tract Infections
2015-09-01AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
2015-08-31PEGASUS-TIMI 54 sub-analysis shows importance of continuing treatment with BRILINTA beyond one year following a heart at...
2015-08-29AstraZeneca to present further research into long-term prevention of cardiovascular events for patients with a history o...
2015-08-24AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
2015-08-24AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial
2015-08-10Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
2015-08-06AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
2015-08-05MedImmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer
2015-08-03AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal dis...
2015-07-30AstraZeneca PLC H1 2015 results
2015-07-27AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
2015-07-22AstraZeneca provides update on selumetinib in uveal melanoma
2015-07-17AstraZeneca completes agreement with Tillotts Pharma for Entocort
2015-07-16AstraZeneca enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan
2015-07-13IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung ...
2015-07-09AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for ...
2015-06-16AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
2015-06-11AstraZeneca reveals findings of archaeological dig as build gets underway at Cambridge Biomedical Campus
2015-06-08New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin c...
2015-06-06AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformi...
2015-06-03AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the American Diabetes Asso...
2015-06-02AstraZeneca updates on immuno-oncology combinations development programme at ASCO 2015
2015-05-30AstraZeneca and MedImmune present positive immuno-oncology combination data at ASCO 2015
2015-05-29AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours
2015-05-22AstraZeneca provides update on brodalumab development programme
2015-05-18AstraZeneca to invest in new biologics manufacturing facility in Södertälje, Sweden, to support accelerating biologics p...
2015-05-13AstraZeneca and Abbott to develop companion diagnostic tests for tralokinumab in severe asthma
2015-05-13AstraZeneca and Montreal Heart Institute to screen 80,000 samples for cardiovascular and diabetes genetic traits
2015-05-13AstraZeneca to update on progress with immuno-oncology pipeline and combination treatments at ASCO 2015
2015-04-29US FDA grants Priority Review for potential new indication for Brilinta
2015-04-24AstraZeneca PLC first quarter results 2015
2015-04-24AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme...
2015-04-24AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-o...
2015-04-17AstraZeneca announces updated progression free survival data for investigational non-small cell lung cancer medicine AZD...
2015-04-17Selumetinib granted Orphan Drug Designation by US FDA for treatment of uveal melanoma
2015-04-16Medimmune and Immunocore announce new collaboration to conduct immuno-oncology combination trials in melanoma
2015-04-15Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma
2015-04-14FDA Advisory Committee reviews SAVOR outcomes study results for ONGLYZA® (saxagliptin) and KOMBIGLYZE® XR (saxagliptin a...
2015-04-13AstraZeneca to showcase strong oncology science at American Association for Cancer Research Annual Meeting 2015
2015-04-13AstraZeneca and PatientsLikeMe announce global research collaboration
2015-03-26AstraZeneca joins Genomics England consortium
2015-03-25AstraZeneca to collaborate with the Harvard Stem Cell Institute in diabetes
2015-03-19AstraZeneca and Daiichi Sankyo to jointly commercialise MOVANTIK in the US
2015-03-18AstraZeneca announces positive Phase III top-line results for PT003 from PINNACLE 1 and PINNACLE 2 studies in COPD
2015-03-14PEGASUS-TIMI 54 study shows that long-term treatment with BRILINTA reduced thrombotic cardiovascular events in patients ...
2015-03-04AstraZeneca to participate in US FDA Endocrinologic and Metabolic Drugs Advisory Committee
2015-03-03AstraZeneca completes acquisition of rights to Actavis’ branded respiratory portfolio in the US and Canada
2015-02-17AstraZeneca announces Non-Executive Board changes
2015-02-13US District Court decision in PULMICORT RESPULES® (budesonide inhalation suspension) patent litigation
2015-02-05AstraZeneca to acquire rights to Actavis’ branded respiratory portfolio in the US and Canada
2015-02-05AstraZeneca PLC fourth quarter and full year results 2014
2015-02-04AstraZeneca receives planning consent for new global R&D centre and corporate headquarters in Cambridge, UK
2015-01-29AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform
2015-01-22Marketing Authorisation Application for gout treatment lesinurad accepted by European Medicines Agency
2015-01-14PEGASUS-TIMI 54 study of BRILINTA® meets primary endpoint in both 60mg and 90mg doses
2015-01-12MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
Brought to you by - Latest Jobs in Pharma
Brought to you by - Latest Jobs in Pharma.